Develops drugs for heart diseases.
Jun 2026Revenue $186M/yrExpenses $227M/yr
No trend
Figures by year
When will Amarin Corp plc\UK be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $186M and expenses $227M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $214M | $264M | −$50.2M |
| Dec 2024 | $229M | $320M | −$91.8M |
| Dec 2023 | $307M | $374M | −$67.6M |
| Dec 2022 | $369M | $475M | −$106M |
| Dec 2021 | $583M | $573M | $10.5M |
| Dec 2020 | $614M | $634M | −$19.7M |
| Dec 2019 | $430M | $454M | −$24.3M |
| Dec 2018 | $229M | $337M | −$108M |
| Dec 2017 | $181M | $227M | −$45.6M |
| Dec 2016 | $130M | $196M | −$65.6M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.